Saratoga Health & Biotechnology Portfolio Fund Class Institutional (SBHIX)

Fund Assets	11.27M
Expense Ratio	2.60%
Min. Investment	$250
Turnover	22.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Dec 9, 2025

Previous Close	29.31
YTD Return	13.39%
1-Year Return	31.98%
5-Year Return	39.58%
52-Week Low	22.94
52-Week High	29.56
Beta (5Y)	0.56
Holdings	27
Inception Date	Jan 27, 2003

About SBHIX

Saratoga Health & Biotechnology Portfolio Fund Class I is a mutual fund focused on the healthcare and biotechnology sectors. Its primary objective is to achieve long-term capital growth by investing at least 80% of its assets in equity securities of U.S. and foreign companies that are actively engaged in health care, health products, pharmaceuticals, and biotechnology industries. The fund’s portfolio typically includes a diverse selection of companies ranging from pharmaceutical developers to providers of medical technologies and health services. Notable features include a relatively concentrated portfolio, with around 45% of assets allocated to its top ten holdings, reflecting an emphasis on select high-impact companies in the sector. The fund is intended for investors seeking exposure to the dynamic healthcare and biotech markets, and it has an institutional share class with a minimum investment of $250. Although the fund has historically provided competitive long-term returns, it carries a higher expense ratio compared to peers, reflecting the active management involved in sector-specific research and selection. Saratoga Health & Biotechnology Portfolio Fund Class I plays a specialized role in the financial market, catering to those interested in the growth potential and innovation within the health and biotechnology fields.

• Fund Family: Saratoga
• Category: Health
• Performance Rating: Average
• Risk Rating: Below Average
• Stock Exchange: NASDAQ
• Ticker Symbol: SBHIX
• Share Class: Class I
• Index: S&P 500 TR

Performance

SBHIX had a total return of 31.98% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.80%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FIKCX	Fidelity	Fidelity Advisor Health Care Z	0.56%
FSPHX	Fidelity	Fidelity Select Health Care Portfolio	0.62%
FIJYX	Fidelity	Fidelity Advisor Biotechnology Z	0.58%
FSHCX	Fidelity	Fidelity Select Health Care Services Portfolio	0.67%
FBTAX	Fidelity	Fidelity Advisor Biotechnology A	0.96%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
SHPAX	Class A	3.00%
SHPCX	Health & Biotechnology Porfolio Class C	3.60%

Top 10 Holdings

51.24% of assets

Name	Symbol	Weight
Cardinal Health, Inc.	CAH	7.35%
Jazz Pharmaceuticals plc	JAZZ	5.96%
United Therapeutics Corporation	UTHR	5.67%
Amgen Inc.	AMGN	5.12%
Lantheus Holdings, Inc.	LNTH	4.90%
McKesson Corporation	MCK	4.71%
Exelixis, Inc.	EXEL	4.63%
Novartis AG ADR	NVSN.MX	4.44%
Cencora, Inc.	COR	4.30%
Johnson & Johnson	JNJ	4.17%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 9, 2025	$0.7788	Dec 10, 2025
Dec 10, 2024	$0.2534	Dec 11, 2024
Dec 8, 2023	$1.0202	Dec 11, 2023
Dec 9, 2022	$1.2749	Dec 12, 2022
Dec 10, 2021	$0.7883	Dec 13, 2021
Dec 11, 2020	$2.5794	Dec 11, 2020

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 28, 2026

Data Sources Report a data error